Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA:603882)
China · Delayed Price · Currency is CNY 30.89
-0.62 (-1.97%)
Sep 18, 2025, 2:45 PM CST
SHA:603882 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -555.7 | -381.24 | 643.38 | 2,755 | 2,220 | 1,510 | Upgrade |
Depreciation & Amortization | 471.5 | 547.6 | 571 | 528.4 | 425.98 | 280.85 | Upgrade |
Other Amortization | 101.96 | 104.82 | 107.57 | 90.46 | 107.99 | 67.79 | Upgrade |
Loss (Gain) From Sale of Assets | -4.83 | -6.36 | -2.2 | -3.99 | 9.74 | -2.11 | Upgrade |
Asset Writedown & Restructuring Costs | 149.79 | 149.96 | 9.77 | 1.02 | 0.37 | 0.67 | Upgrade |
Loss (Gain) From Sale of Investments | 136.99 | 140.82 | -262.97 | 10.8 | 7.29 | 18.66 | Upgrade |
Provision & Write-off of Bad Debts | 595.43 | 618.94 | 488.41 | 255.31 | 71.09 | 46.93 | Upgrade |
Other Operating Activities | -22.01 | -15.02 | 14.13 | 105.32 | 172.8 | 93.36 | Upgrade |
Change in Accounts Receivable | 936.31 | 263.52 | 1,247 | -2,702 | -2,116 | -1,277 | Upgrade |
Change in Inventory | 37.88 | 49.89 | 157.42 | -58.82 | -107.02 | -66.62 | Upgrade |
Change in Accounts Payable | -472.52 | -413.54 | -1,633 | 891.85 | 1,162 | 796.25 | Upgrade |
Change in Other Net Operating Assets | -48.72 | -33.19 | -40.89 | 102.14 | 133.14 | 45.88 | Upgrade |
Operating Cash Flow | 1,223 | 906.35 | 1,231 | 1,948 | 2,088 | 1,523 | Upgrade |
Operating Cash Flow Growth | 34.13% | -26.36% | -36.81% | -6.71% | 37.09% | 130.29% | Upgrade |
Capital Expenditures | -412.84 | -446.36 | -714.75 | -840.54 | -952.42 | -550.65 | Upgrade |
Sale of Property, Plant & Equipment | 14.83 | 15.2 | 18.94 | 20.37 | 73.23 | 10.61 | Upgrade |
Cash Acquisitions | - | - | -6.7 | -22.09 | - | -19.96 | Upgrade |
Divestitures | - | - | 218.03 | - | - | - | Upgrade |
Investment in Securities | -47.6 | -25.88 | -150.29 | -8.52 | -131.98 | -74.38 | Upgrade |
Other Investing Activities | 2.86 | 1.51 | 0.23 | 2.41 | 1.55 | 0.03 | Upgrade |
Investing Cash Flow | -442.75 | -455.53 | -634.53 | -848.37 | -1,010 | -634.35 | Upgrade |
Long-Term Debt Issued | - | 368.84 | 206.26 | 80 | - | 463.54 | Upgrade |
Long-Term Debt Repaid | - | -219.76 | -330.43 | -295.51 | -187.63 | -616.32 | Upgrade |
Net Debt Issued (Repaid) | 34.38 | 149.08 | -124.16 | -215.51 | -187.63 | -152.78 | Upgrade |
Issuance of Common Stock | - | - | 41.76 | 36.63 | 342.13 | 46.15 | Upgrade |
Repurchase of Common Stock | - | -210 | -89.99 | - | - | - | Upgrade |
Common Dividends Paid | -417.67 | -419.57 | -839.33 | -609.52 | -169.98 | -91.92 | Upgrade |
Other Financing Activities | -22.51 | -8.31 | -50.29 | -80.17 | -37.54 | -15.84 | Upgrade |
Financing Cash Flow | -405.81 | -488.8 | -1,062 | -868.57 | -53.03 | -214.38 | Upgrade |
Foreign Exchange Rate Adjustments | 0.77 | 10.83 | 7.39 | 38.95 | -11.46 | -3.76 | Upgrade |
Net Cash Flow | 374.73 | -27.15 | -458.34 | 269.86 | 1,014 | 670.62 | Upgrade |
Free Cash Flow | 809.69 | 459.99 | 516.07 | 1,107 | 1,136 | 972.45 | Upgrade |
Free Cash Flow Growth | 189.83% | -10.87% | -53.39% | -2.49% | 16.77% | 151.62% | Upgrade |
Free Cash Flow Margin | 12.84% | 6.40% | 6.04% | 7.16% | 9.51% | 11.80% | Upgrade |
Free Cash Flow Per Share | 1.74 | 0.99 | 1.11 | 2.37 | 2.44 | 2.11 | Upgrade |
Cash Income Tax Paid | 81.74 | 182.67 | 392.94 | 587.14 | 294.69 | 163.63 | Upgrade |
Levered Free Cash Flow | 923.39 | 530.61 | 292.07 | 284.4 | 502.44 | 536.63 | Upgrade |
Unlevered Free Cash Flow | 934.09 | 542.13 | 304.82 | 299.18 | 519.66 | 554.91 | Upgrade |
Change in Working Capital | 349.4 | -253.18 | -338.27 | -1,794 | -926.93 | -492.76 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.